Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last kr6.75 SEK
Change Today -0.20 / -2.88%
Volume 1.6K
ADDV On Other Exchanges
As of 6:59 AM 04/30/15 All times are local (Market data is delayed by at least 15 minutes).

addvise lab solutions ab (ADDV) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/5/14 - kr8.20
52 Week Low
12/16/14 - kr5.50
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

addvise lab solutions ab (ADDV) Related Businessweek News

No Related Businessweek News Found

addvise lab solutions ab (ADDV) Details

ADDvise Lab Solutions AB (publ), through its subsidiaries, provides various products and services to healthcare and research environments in private and public sector primarily in the Nordic region. The company’s products include laboratory furnishings, protective ventilations, laboratory equipment, and clean rooms/climate rooms; and customized special solutions in the industrial ventilation segment, as well as clean room solutions. It serves pharmaceuticals, hospitals, food industry, universities/colleges, and heavy and light industries. The company is based in Bromma, Sweden.

addvise lab solutions ab (ADDV) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

addvise lab solutions ab (ADDV) Key Developments

ADDvise Lab Solutions AB Provides Earnings Guidance for the Year 2015

ADDvise Lab Solutions AB provided earnings guidance for the year 2015. The start of the first quarter 2015 has been strong in terms of new orders and the outlook for ADDvise markets looks favorable also for the rest of the year. This, in combination with the fact that efficiency improvements carried out during 2013 and 2014 are starting to show results, make the board of directors expect a turnover for 2015 in the range of SEK 160-170 million with an EBITDA margin before any acquisition costs of at least 7%.

ADDvise Receives Order from Astrazeneca in China to Deliver Laboratory Furnishings and Safety Ventilation

ADDvise has received an order from AstraZeneca in Wuxi, China, to deliver laboratory furnishings and safety ventilation to a chemistry laboratory and a microbiology laboratory. The order amounts to SEK 2.2 and will be delivered during 2015. The order will be delivered to AstraZeneca\'s research and development laboratory in Wuxi.

ADDvise Group Revises Earnings Guidance for the Year 2014

ADDvise Group revised earnings guidance for the year 2014. The group has had a positive turnover growth in 2014. However, a slightly weaker than-expected sales in the fourth quarter has resulted in that the previously announced turnover and EBITDA forecast of SEK 149 million and SEK 11 million will not be met. Net sales for the full year 2014 is estimated to approximately SEK 138 million with an EBITDA before acquisition costs of approximately SEK 6.8 million in accordance with IFRS. The corresponding numbers for 2013 amounted to SEK 120 million in net sales and EBITDA before acquisition costs of SEK 6.1 million. A shift of orders from the fourth quarter 2014 to the first quarter 2015 is the main reason why the full year forecast will not be met.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ADDV:SS kr6.75 SEK -0.20

ADDV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ADDV.
View Industry Companies

Industry Analysis


Industry Average

Valuation ADDV Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.3x
Price/Book 3.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ADDVISE LAB SOLUTIONS AB, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at